Found 21 matching trials
A Study of Tobramycin Inhalation Powder From a Modified Manufacturing Process Versus Placebo PHASE3 This study is designed to show how well tobramycin inhalation powder works ...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Human Factors Study to Validate the User Interface of TOBI Podhaler Using Placebo Capsules PHASE4 The purpose of this study is to validate the user interface of TOBI Podhale...
Show More Location
Batchelor Childrens Research Institute
Learn More & Join Trial
Pharmacokinetic and Pharmacoscintigraphic Comparison of TobrAir® 6.0 With TOBI® and TOBI® Podhaler™ PHASE1 This study compares pharmacokinetic profiles of tobramycin delivered by Tob...
Show More Location
Quotient Clinical
Learn More & Join Trial
Dose-finding Study to Assess the Efficacy, Safety and Tolerability of Tobramycin Inhalation Powder in Patients With Non-Cystic Fibrosis Bronchiectasis and Pulmonary P. Aeruginosa Infection PHASE2 The purpose of this study was to support the selection of a safe and tolera...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Combined Dry Powder Tobramycin and Nebulized Colistin Inhalation in CF Patients PHASE3 To assess whether the inhalative combination of Tobramycin/Colistin is more...
Show More Location
Multiple Locations
Learn More & Join Trial
Tobramycin Inhalation Powder (TIP) Administered Once Daily Continuously Versus TIP Administered BID in 28 Day on / 28 Day Off Cycles PHASE4 To provide efficacy and safety data comparing two dosing schedules of Tobra...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Efficacy of TOBI Podhaler vs. Tobramycin Inhalation Solution N/A Inhaled tobramycin is a Cystic Fibrosis Foundation recommended effective tr...
Show More Location
Rush University Medical Center
Learn More & Join Trial
Evaluation of Lung Clearance Index in Cystic Fibrosis (CF) Patients, Infected With P.Aeruginosa PHASE4 The purpose of the study was to evaluate lung clearance index (LCI) by a st...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Study to Validate the Instructions for Use of TOBI® Podhaler™ in Cystic Fibrosis Patients PHASE4 The purpose of this actual use human factors (HF) study is to validate the ...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Observational Study in Cystic Fibrosis Patients Using TOBI® PODHALER® or Other FDA Approved Inhaled Antipseudomonal Antibacterial Drugs N/A This is a multicenter, prospective, two cohort, observational study over a ...
Show More Location
Novartis Investigative Site
Learn More & Join Trial